The present stock price for Oncolytics Biotech, Inc (ONCY) is $1.08. In the last trading session, the stock made a considerable jump, reaching $6.98 after an opening price of $1.08. The stock briefly fell to $2.99 before ending the session at $0.94.
Oncolytics Biotech, Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $1.53 on 10/07/24, while the lowest price for the same period was registered at $0.33 on 06/06/25.
52-week price history of ONCY Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Oncolytics Biotech, Inc’s current trading price is -29.41% away from its 52-week high, while its distance from the 52-week low is 231.49%. The stock’s price range during the 52-week period has remained between $0.33 and $1.53. In the Healthcare sector, the company’s shares saw a trading volume of around 0.87 million for the day, which was evidently lower than the average daily volume of 1.24 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Oncolytics Biotech, Inc (ONCY) has experienced a quarterly rise of 115.87% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 104.33M and boasts a workforce of 28 employees.
A Closer Look at Analysts’ Ratings for Oncolytics Biotech, Inc
As of right now, 2 analysts are rating Oncolytics Biotech, Inc as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7054, with a change in price of +0.4507. Similarly, Oncolytics Biotech, Inc recorded 894,734 in trading volume during the last 100 days, posting a change of +71.62%.
Examining ONCY’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ONCY stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.10.
ONCY Stock Stochastic Average
As of today, Oncolytics Biotech, Inc’s raw stochastic average for the last 50 days stands at 73.64%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 56.46%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 40.98% and 29.29%, respectively.
ONCY Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 18.64% this year. Over the last six months, there has been a weaker performance of 39.88%. The price of ONCY leaped by -18.18% during the last 30 days period. For the last 5-days stocks have improved 25.82%.
